As part of our efforts to combat the Covid-19 pandemic, We have designed and expressed a panel of unique recombinant protein antigens to assist in the search for a neutralising therapeutic antibody against SARS-CoV 2.
Fusion Antibodies have named A-Frontier as their exclusive supplier in South Korea
Fusion Antibodies have named BioTickle as their exclusive distributor in India to provide access to proprietary antibody discovery, engineering and cell line development technologies.
Finding a high-affinity antibody that binds to your target is only the first step.
A new research alliance has been formed to seek new therapeutic and diagnostic approaches to help in the global fight against the coronavirus pandemic.
Advancing towards the clinic. What’s happening in the industry in the fight against COVID-19?
